Multimarkers Of Metabolic Malnutrition And Inflammation And Their Association With Mortality Risk In Cardiac Catheterisation Patients A Prospective, Longitudinal, Observational, Cohort Study

Researchers studied whether a combination of blood markers could better predict mortality risk in patients with heart disease. They focused on metabolic dysfunction - problems with how the body processes nutrients and energy - combined with inflammation, which together can contribute to conditions like muscle wasting, malnutrition, and frailty that increase death risk, especially in older adults and those with chronic diseases.

The study followed patients who underwent cardiac catheterization (a heart procedure) at two medical centers over several years. Scientists measured six specific biomarkers in blood samples: GlycA (an inflammation marker), small HDL particles, three amino acids (valine, leucine, and isoleucine), and citrate. They combined these measurements into a single score called the Metabolic Vulnerability Index (MVX) to assess each patient's metabolic health status.

The research found that patients with higher MVX scores - indicating worse metabolic dysfunction and inflammation - had significantly higher rates of death over the follow-up period. This held true even after accounting for other known risk factors. The combination of biomarkers was more predictive than individual markers alone, suggesting that metabolic health involves multiple interconnected systems in the body.

This research is significant because it provides a more objective way to identify patients at higher risk due to metabolic dysfunction, rather than relying on clinical observations alone. For metabolic health and longevity, this suggests that monitoring inflammation and metabolic markers together may help identify people who could benefit from targeted interventions to improve their nutritional status, reduce inflammation, and preserve muscle mass before more serious complications develop.